Sites chosen for public-private Osteoarthritis Initiative

Four clinical centers and a data coordinating center have been selected to conduct the Osteoarthritis Initiative (OAI), the public-private partnership that will bring together new resources and commitment to help find biological and structural markers (biomarkers) for development and progression of this joint disease. Osteoarthritis is the most common form of arthritis and the major cause of activity limitation and physical disability in older people.

The seven-year project will recruit 5,000 men and women aged 50 and above at high risk for developing symptomatic knee osteoarthritis. The OAI will rely on the following centers and their principal investigators:

University of Maryland School of Medicine, Baltimore; Marc Hochberg, M.D., M.P.H.

The Ohio State University, Columbus; Rebecca Jackson, M.D.

University of Pittsburgh; C. Kent Kwoh, M.D.

Memorial Hospital of Rhode Island, Pawtucket; Annlouise Assaf, Ph.D., F.A.H.A.

University of California, San Francisco (data coordinating center); Michael Nevitt, Ph.D.

The initiative should help speed OA drug development, which is hindered by the lack of objective and measurable standards for disease progression needed for drug evaluation.

The OAI consortium includes public funding from the National Institutes of Health (NIH) and private funding from several pharmaceutical companies: GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Pfizer. The consortium is being facilitated by the Foundation for the National Institutes of Health. The OAI will allow the centers to establish and maintain a natural history database for osteoarthritis that will include clinical evaluation data and radiological (x-ray and magnetic resonance) images, and a biospecimen repository. All data and images collected will be available

Contact: Ray Fleming
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Page: 1 2 3

Related medicine news :

1. Sexually Oriented Internet Sites Are Popular And Non-Problematic For Most People, But Pose Risks For Some
2. UW-Madison Center One Of Two Sites Nationwide Selected For Clinical Trial Of Cancer Drug
3. University Of Pittsburgh Chosen By NCI As One Of Three Pioneer Sites ForBiocombinatorial Chemistry Research
4. Duke Study Uses Tiny Temperature Changes To Probe Water-Exclusion At Protein Binding Sites
5. Northwestern Memorial chosen to be featured in first-ever mini-med school TV airing on PBS
6. UCIs Brain Imaging Center chosen to help advance nations Roadmap for Medical Research
7. Rochester chosen to focus on rare neurological diseases
8. Regional consortium of universities chosen for biodefense initiative
9. U of MN Vet Diagnostic Lab chosen by CDC as monkeypox testing site
10. Nine chosen to receive funding for geriatric social work research
11. Columbia dental students chosen for three out of nine NIH summer fellowships in national competition

Post Your Comments:

(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
Breaking Medicine Technology:
Cached News: